Crest Pro-Health Oral Rinse Recalled for Cross-Contamination
Procter & Gamble is recalling Crest Pro-Health Oral Rinse because it was mixed with another type of mouthwash.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which indicates the product is not likely to cause adverse health consequences, fitting the criteria for a moderate severity score.
Plain-English summary
Procter & Gamble is recalling Crest PRO-HEALTH CPC Antigingivitis/Antiplaque Oral Rinse, 250 mL bottles. The recall involves 71,040 bottles distributed nationwide.
The recall was initiated because the product was mixed with another type of mouthwash, resulting in cross-contamination. The affected product has the code 22155395UA and an expiration date of 07/2014.
Consumers should stop using the affected product and return it to the place of purchase for a refund or contact the manufacturer for further instructions.
The recalled product
- Product
- Crest PRO-HEALTH CPC Antigingivitis/Antiplaque Oral Rinse, 250 mL (8.4 fl oz),Dist. by Procter & Gamble, Cincinnati, OH 45202 NDC 37000-452-02
- Manufacturer
- Procter & Gamble Hair Care Llc
- Category
- Drug — Oral Care
- Hazard
- Affected units
- 71,040
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- 22155395UA Expires: 07/2014
Distribution
Distributed nationwide across the United States.
Related recalls
Same hazard · cross contamination
See all →- CriticalCetirizine Hydrochloride Tablets Recalled Due to Cross Contamination with Ranitidine
FDA (Drugs) · 2026-07-29
- ModeratePrimidone tablets recalled over potential acemetacin cross-contamination at API manufacturer
FDA (Drugs) · 2026-06-17
- HighFly By Jing creamy sesame noodles may contain undeclared peanut
FDA (Food) · 2026-06-03
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets 50 mg Recalled for API Cross-Contamination
FDA (Drugs) · 2026-05-27